Abstract
The effects of anti-acetylcholine receptor (AChR) monoclonal antibodies (mAbs) 370 and 132A on miniature end-plate potentials (MEPPs) and end-plate currents (EPCs) in the posterior lattisimus dorsi muscle of adult chickens were investigated. After incubation of the electrophysiological preparation with mAb 370 (5-50 μg/ml), which blocks both agonist (carbamylcholine) and α-bungarotoxin (α-BTX) binding and induces a hyperacute form of experimental autoimmune myasthenia gravis (EAMG), MEPP and EPC amplitudes were irreversibly reduced. This effect was not associated with any significant change in the time constant describing EPC decay (τ(EPC)), current reversal potential, or the voltage dependence of τ(EPC). The τ(EPC) at -80 mV was 5.9 ± 0.6 ms before incubation with mAb 370 (50 μg/ml) and 6.0 ± 0.9 ms afterwards. Current reversal potential was -3.9 ± 0.4 mV before mAb incubation and -4.8 ± 1.5 mV afterwards. The change in membrane potential required to produce an e-fold change in τ(EPC) was 128 ± 2.3 mV before antibody incubation compared to 125 ± 6.6 mV after incubation. A second anti-AChR mAb, 132A (50 μg/ml), which is capable of inducing the classically described form of EAMG without blocking agonist or α-BTX binding, or inducing hyperacute EAMG, produced no significant change in MEPP amplitude, EPC amplitude τ(EPC) or EPC reversal potentials. The mAb 370 (50 μg/ml) induced a partially reversible decrease of the quantal content of the neurally evoked end-plate potential (EPP). This effect was not observed with mAb 132A, (+)tubocurarine (10-7 - 10-5 g/ml) or an irrelevant anti-oestrogen receptor mAb. These data suggest that the rapid onset of weakness observed in chicken hatchlings after the injection of mAb 370 (Gomez & Richman, 1983) can be attributed to a combined effect of a block of acetylcholine (ACh)-induced ion channel activity in the postsynaptic membrane and a reduction of the neutrally evoked release of acetylcholine from the nerve terminal.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 271-283 |
| Number of pages | 13 |
| Journal | Journal of Physiology |
| Volume | 411 |
| State | Published - 1989 |
| Externally published | Yes |
Fingerprint
ASJC Scopus subject areas
- Physiology
Cite this
Effects of a monoclonal anti-acetylcholine receptor antibody on the avian end-plate. / Maselli, Ricardo A; Nelson, D. J.; Richman, David P.
In: Journal of Physiology, Vol. 411, 1989, p. 271-283.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Effects of a monoclonal anti-acetylcholine receptor antibody on the avian end-plate
AU - Maselli, Ricardo A
AU - Nelson, D. J.
AU - Richman, David P
PY - 1989
Y1 - 1989
N2 - The effects of anti-acetylcholine receptor (AChR) monoclonal antibodies (mAbs) 370 and 132A on miniature end-plate potentials (MEPPs) and end-plate currents (EPCs) in the posterior lattisimus dorsi muscle of adult chickens were investigated. After incubation of the electrophysiological preparation with mAb 370 (5-50 μg/ml), which blocks both agonist (carbamylcholine) and α-bungarotoxin (α-BTX) binding and induces a hyperacute form of experimental autoimmune myasthenia gravis (EAMG), MEPP and EPC amplitudes were irreversibly reduced. This effect was not associated with any significant change in the time constant describing EPC decay (τ(EPC)), current reversal potential, or the voltage dependence of τ(EPC). The τ(EPC) at -80 mV was 5.9 ± 0.6 ms before incubation with mAb 370 (50 μg/ml) and 6.0 ± 0.9 ms afterwards. Current reversal potential was -3.9 ± 0.4 mV before mAb incubation and -4.8 ± 1.5 mV afterwards. The change in membrane potential required to produce an e-fold change in τ(EPC) was 128 ± 2.3 mV before antibody incubation compared to 125 ± 6.6 mV after incubation. A second anti-AChR mAb, 132A (50 μg/ml), which is capable of inducing the classically described form of EAMG without blocking agonist or α-BTX binding, or inducing hyperacute EAMG, produced no significant change in MEPP amplitude, EPC amplitude τ(EPC) or EPC reversal potentials. The mAb 370 (50 μg/ml) induced a partially reversible decrease of the quantal content of the neurally evoked end-plate potential (EPP). This effect was not observed with mAb 132A, (+)tubocurarine (10-7 - 10-5 g/ml) or an irrelevant anti-oestrogen receptor mAb. These data suggest that the rapid onset of weakness observed in chicken hatchlings after the injection of mAb 370 (Gomez & Richman, 1983) can be attributed to a combined effect of a block of acetylcholine (ACh)-induced ion channel activity in the postsynaptic membrane and a reduction of the neutrally evoked release of acetylcholine from the nerve terminal.
AB - The effects of anti-acetylcholine receptor (AChR) monoclonal antibodies (mAbs) 370 and 132A on miniature end-plate potentials (MEPPs) and end-plate currents (EPCs) in the posterior lattisimus dorsi muscle of adult chickens were investigated. After incubation of the electrophysiological preparation with mAb 370 (5-50 μg/ml), which blocks both agonist (carbamylcholine) and α-bungarotoxin (α-BTX) binding and induces a hyperacute form of experimental autoimmune myasthenia gravis (EAMG), MEPP and EPC amplitudes were irreversibly reduced. This effect was not associated with any significant change in the time constant describing EPC decay (τ(EPC)), current reversal potential, or the voltage dependence of τ(EPC). The τ(EPC) at -80 mV was 5.9 ± 0.6 ms before incubation with mAb 370 (50 μg/ml) and 6.0 ± 0.9 ms afterwards. Current reversal potential was -3.9 ± 0.4 mV before mAb incubation and -4.8 ± 1.5 mV afterwards. The change in membrane potential required to produce an e-fold change in τ(EPC) was 128 ± 2.3 mV before antibody incubation compared to 125 ± 6.6 mV after incubation. A second anti-AChR mAb, 132A (50 μg/ml), which is capable of inducing the classically described form of EAMG without blocking agonist or α-BTX binding, or inducing hyperacute EAMG, produced no significant change in MEPP amplitude, EPC amplitude τ(EPC) or EPC reversal potentials. The mAb 370 (50 μg/ml) induced a partially reversible decrease of the quantal content of the neurally evoked end-plate potential (EPP). This effect was not observed with mAb 132A, (+)tubocurarine (10-7 - 10-5 g/ml) or an irrelevant anti-oestrogen receptor mAb. These data suggest that the rapid onset of weakness observed in chicken hatchlings after the injection of mAb 370 (Gomez & Richman, 1983) can be attributed to a combined effect of a block of acetylcholine (ACh)-induced ion channel activity in the postsynaptic membrane and a reduction of the neutrally evoked release of acetylcholine from the nerve terminal.
UR - http://www.scopus.com/inward/record.url?scp=0024504675&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0024504675&partnerID=8YFLogxK
M3 - Article
C2 - 2614725
AN - SCOPUS:0024504675
VL - 411
SP - 271
EP - 283
JO - Journal of Physiology
JF - Journal of Physiology
SN - 0022-3751
ER -